UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | U | V | W
Number of items: 157.

A

Aballea, S; Chancellor, JVM; Raikou, M; Drummond, MF; Weinstein, MC; Jourdan, S; Bridgewater, J; (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. CANCER , 109 (6) pp. 1082-1089. 10.1002/cncr.22512.

Aguilar, V; Alliouachene, S; Sotiropoulos, A; Sobering, A; Athea, Y; Djouadi, F; Miraux, S; (2007) S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab , 5 (6) pp. 476-487. 10.1016/j.cmet.2007.05.006.

Ah-See, M-L.W.; (2007) Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer. Doctoral thesis, University of London. Green open access
file

Ahmed, AA; Mills, AD; Ibrahim, AEK; Temple, J; Blenkiron, C; Vias, M; Massie, CE; (2007) The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell , 12 (6) pp. 514-527. 10.1016/j.ccr.2007.11.014.

Al-Alwan, MM; Okkenhaug, K; Vanhaesebroeck, B; Hayflick, JS; Marshall, AJ; (2007) Requirement for phosphoinositide 3-kinase p110 delta signaling in B cell antigen receptor-mediated antigen presentation. JOURNAL OF IMMUNOLOGY , 178 (4) pp. 2328-2335.

Allen, OR; Gott, AL; Hartley, JA; Hartley, JM; Knox, RJ; McGowan, PC; (2007) Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs. DALTON T (43) 5082 - 5090. 10.1039/b708283p.

Alonzi, R; Padhani, AR; Taylor, NJ; Stirling, JJ; Saunders, MI; Hoskin, PJ; (2007) Physiological changes within the prostate caused by androgen withdrawal. In: (pp. S6-S6).

Arkenau, H-T; Chong, G; Cunningham, D; Watkins, D; Agarwal, R; Sirohi, B; Trumper, M; (2007) The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Ann Oncol , 18 (3) pp. 541-545. 10.1093/annonc/mdl434.

Arkenau, H-T; Chong, G; Cunningham, D; Watkins, D; Sirohi, B; Chau, I; Wotherspoon, A; (2007) Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica , 92 (2) pp. 271-272.

Arkenau, H-T; Chua, YJ; Cunningham, D; (2007) Current treatment strategies in elderly patients with metastatic colorectal cancer. Clin Colorectal Cancer , 6 (7) pp. 508-515.

Arkenau, H-T; Gordon, C; Cunningham, D; Norman, A; Wotherspoon, A; Chau, I; (2007) Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience. Leuk Lymphoma , 48 (3) pp. 547-550. 10.1080/10428190601094388.

Arkenau, H-T; Gordon, C; Murphy, F; Cunningham, D; (2007) Paraneoplastic syndrome: subacute cerebellar degeneration in Hodgkin's disease. Leuk Lymphoma , 48 (4) pp. 819-822. 10.1080/10428190601164249.

Ayaru, L; Pereira, SP; Alisa, A; Pathan, AA; Williams, R; Davidson, B; Burroughs, AK; (2007) Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J IMMUNOL , 178 (3) 1914 - 1922.

B

Bajwa, A; Blunt, N; Vyas, S; McKenzie, G; Bridgewater, J; Hochhauser, D; Obichere, A; (2007) Predictive factors of outcome in patients with asymptomatic stage IV colorectal cancer and irresectable liver metastases. In: (pp. V1170-V1170).

Begent, RH; (2007) Interpretation of treatment results with biological agents: is there a need for a new methodology? J BUON , 12 Sup S53-S58.

Begent, RHJ; Sharma, SK; Mayer, A; Tolner, B; Pedley, RB; Wilkins, D; Kogelberg, H; (2007) Incorporating single chain Fv antibodies into therapeutic proteins: issues exemplified in antibody-directed enzyme prodrug therapy (ADEPT). In: IMMUNOLOGY. (pp. 42 - 42). BLACKWELL PUBLISHING

Beresford, M; Lyburn, I; Sanghera, B; Makris, A; Wong, WL; (2007) Serial integrated F-18-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma. BLACKWELL PUBLISHING

Beresford, MJ; Ravichandran, D; Makris, A; (2007) Neoadjuvant endocrine therapy in breast cancer. Cancer Treatment Reviews , 33 (1) pp. 48-57.

Bilanges, B; Argonza-Barrett, R; Kolesnichenko, M; Skinner, C; Nair, M; Chen, M; Stokoe, D; (2007) Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner. Mol Cell Biol , 27 (16) pp. 5746-5764. 10.1128/MCB.02136-06.

Bilanges, B; Stokoe, D; (2007) Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene , 26 (41) pp. 5973-5990. 10.1038/sj.onc.1210431.

Birney, E; Stamatoyannopoulos, JA; Dutta, A; Guigo, R; Gingeras, TR; Margulies, EH; Weng, ZP; (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. NATURE , 447 (7146) 799 - 816. 10.1038/nature05874.

Boone, J.J.M.; (2007) The role of ErbB2 and BRCA1 in repair of drug-induced DNA damage. Doctoral thesis, University of London. Green open access
file

Brown, T; Taherbhai, Z; Sexton, J; Sutterfield, A; Turlington, M; Jones, J; Stallings, L; (2007) Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin. BIOORGAN MED CHEM , 15 (1) 474 - 483. 10.1016/j.bmc.2006.09.037.

Buchler, T; Bomanji, J; Lee, SM; (2007) FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica , 92 (11) e120-e121. 10.3324/haematol.11856. Gold open access

Burdak-Rothkamm, S; Short, S; Folkard, M; Rothkamm, K; Prise, KM; (2007) ATR-Dependent Radiation Induced g-H2AX Foci In Bystander Primary Human Astrocytes And Glioma Cells. Oncogene , 26 (7) pp. 993-1002. 10.1038/sj.onc.1209863.

Byrne, RD; Rosivatz, E; Parsons, M; Larijani, B; Parker, PJ; Ng, T; Woscholski, R; (2007) Differential activation of the PI 3-kinase effectors AKT/PKB and p70 S6 kinase by compound 48/80 is mediated by PKCalpha. Cell Signal , 19 (2) pp. 321-329. 10.1016/j.cellsig.2006.07.004.

C

Chong, IY; Hoskin, PJ; (2007) Vaginal vault brachytherapy for low risk endometrial carcinoma. In: (pp. S8-S8).

Chong, IY; Rojas, A; Hoskin, PJ; (2007) Does a fall in lymphocyte or neutrophil count during chemoradiotherapy predict survival in cervical carcinoma? In: (pp. S25-S26).

Chowdhury, T.; (2007) Investigation of the role of MLL-ENL in leukaemogenesis. Doctoral thesis, University of London. Green open access
file

Clingen, PH; Arlett, CF; Hartley, JA; Parris, CN; (2007) Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links. EXP CELL RES , 313 (4) 753 - 760. 10.1016/j.yexcr.2006.11.007.

Cutillas, PR; Vanhaesebroeck, B; (2007) Quantitative profile of five murine core proteomes using label-free functional proteomics. MOLECULAR & CELLULAR PROTEOMICS , 6 (9) pp. 1560-1573. 10.1074/mcp.M700037-MCP200.

D

Dancey, G; Violet, J; Othman, S; Parker, S; Green, A; Sharma, S; Francis, R; (2007) Phase I trial of the I-131-labelled Anti-CD25 antibody basiliximab in the treatment of patients with relapsed or refractory lymphoma. In: BLOOD. (pp. 199A - 200A). AMER SOC HEMATOLOGY

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2007) Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy. CLIN CANCER RES , 13 (6) 1903 - 1910. 10.1158/1078-0432.CCR-06-2094.

Diez, P; Hoskin, PJ; (2007) Conventional and CT-based volumes in IFRT for supradiaphragmatic malignant lymphoma. In: (pp. S16-S16).

de Bruin, EC; van de Pas, S; van de Velde, CJH; van Krieken, JHJM; Peltenburg, LTC; Marijnen, CAM; Medema, JP; (2007) Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo. Apoptosis , 12 (9) pp. 1671-1680. 10.1007/s10495-007-0088-2.

de Heer, P; Gosens, MJEM; de Bruin, EC; Dekker-Ensink, NG; Putter, H; Marijnen, CAM; van den Brule, AJC; (2007) Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy. Clin Cancer Res , 13 (10) pp. 2955-2960. 10.1158/1078-0432.CCR-06-2042.

de Heer, P; de Bruin, EC; Klein-Kranenbarg, E; Aalbers, RIJM; Marijnen, CAM; Putter, H; de Bont, HJ; (2007) Caspase-3 activity predicts local recurrence in rectal cancer. Clin Cancer Res , 13 (19) pp. 5810-5815. 10.1158/1078-0432.CCR-07-0343.

E

Eickholt, BJ; Ahmed, AI; Davies, M; Papakonstanti, EA; Pearce, W; Starkey, ML; Bilando, A; (2007) Control of Axonal Growth and Regeneration of Sensory Neurons by the p110 delta PI 3-Kinase. PLOS ONE , 2 (9) , Article e869. 10.1371/journal.pone.0000869. Green open access
file

El Emir, E; Qureshi, U; Dearling, JLJ; Boxer, GM; Clatworthy, I; Folarin, AA; Robson, MP; (2007) Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. CANCER RES , 67 (24) 11896 - 11905. 10.1158/0008-5472.CAN-07-2967.

El-Emir, E; Dearling, JLJ; Huhalov, A; Robson, MP; Boxer, G; Neri, D; van Dongen, GAMS; (2007) Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models. BRIT J CANCER , 96 (12) 1862 - 1870. 10.1038/sj.bjc.6603806. Gold open access

Ellis, T; Evans, DA; Martin, CRH; Hartley, JA; (2007) A 96-well DNase I footprinting screen for drug-DNA interactions. NUCLEIC ACIDS RES , 35 (12) , Article e89. 10.1093/nar/gkm467. Gold open access

F

Forster, M; Kaye, S; Oza, A; Sklenar, I; Johri, A; Cheung, W; Zaknoen, S; (2007) A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer. Clin Cancer Res , 13 (14) pp. 4178-4184. 10.1158/1078-0432.CCR-06-1653.

Forster, MD; Ormerod, MG; Agarwal, R; Kaye, SB; Jackman, AL; (2007) Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells. Cytometry A , 71 (11) pp. 945-950. 10.1002/cyto.a.20456.

Fox, J; Glasspool, D; Grecu, D; Modgil, S; South, M; Patkar, V; (2007) Argumentation-based inference and decision making - A medical perspective. IEEE INTELL SYST , 22 (6) 34 - 41.

Furnari, FB; Fenton, T; Bachoo, RM; Mukasa, A; Stommel, JM; Stegh, A; Hahn, WC; (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev , 21 (21) pp. 2683-2710. 10.1101/gad.1596707.

G

Geering, B; Cutillas, PR; Nock, G; Gharbi, SI; Vanhaesebroeck, B; (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 104 (19) pp. 7809-7814. 10.1073/pnas.0700373104.

Geering, B; Cutillas, PR; Vanhaesebroeck, B; (2007) Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? In: (Proceedings) 3rd Focused Meeting on PI3K Signalling and Disease. (pp. pp. 199-203). PORTLAND PRESS LTD

Gunaratnam, M; Greciano, O; Martins, C; Reszka, AP; Schultes, CM; Morjani, H; Riou, J-F; (2007) Mechanism of acridine-based telomerase inhibition and telomere shortening. Biochem Pharmacol , 74 (5) pp. 679-689. 10.1016/j.bcp.2007.06.011.

H

Hochhauser, D; Kotecha, M; O'Hare, C; Morris, PJ; Hartley, JM; Taherbhai, Z; Harris, D; (2007) Modulation of topoisomerase II alpha expression by a DNA sequence-specific polyamide. MOL CANCER THER , 6 (1) 346 - 354. 10.1158/1535-7163.MCT-06-0503.

Hochhauser, D; Kotecha, M; O'Hare, C; Morris, PJ; Hartley, JM; Taherbhai, Z; Harris, D; (2007) Modulation of topoisomerase II expression in mammalian cells with a sequence-specific polyamide. Molecular Cancer Therapeutics , 6 (1) pp. 346-354.

Hoskin, PJ; Bownes, P; Bryant, L; Ostler, P; (2007) HDR monotherapy brachytherapy for localised prostate cancer. In: (pp. S7-S7).

Hoskin, PJ; Carnell, DM; Taylor, NJ; Smith, RE; Stirling, JJ; Daley, FM; Saunders, MI; (2007) Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 68 (4) pp. 1065-1071.

Hoskin, PJ; Chin, Y; Wong, W; Rojas, A; (2007) The value of SUV in FDG PET for lymphoma. In: (pp. S32-S32).

Hoskin, PJ; Dearnaley, DP; (2007) Hypofractionation in clinical trials for prostate cancer. ELSEVIER SCIENCE LONDON

Hoskin, PJ; Motohashi, K; Bownes, P; Bryant, L; Ostler, P; (2007) High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiotherapy & Oncology , 84 (2) pp. 114-120.

Hoskin, PJ; Venselaar, J; (2007) Prostate brachytherapy in Europe: Growth, practice and guidelines. UNSPECIFIED

Howie, AJ; (2007) The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome. Transplantation , 83 (4) pp. 373-374. 10.1097/01.tp.0000251424.65487.5c.

Huddart, RA; O'Doherty, MJ; Padhani, A; Rustin, GJ; Mead, GM; Joffe, JK; Vasey, P; (2007) 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group. Clinical Oncology , 25 (11) pp. 1310-1315.

J

Jain, P; Cerone, MA; Leblanc, AC; Autexier, C; (2007) Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons. J Neurosci Res , 85 (1) pp. 83-89. 10.1002/jnr.21094.

Ji, H; Rintelen, F; Waltzinger, C; Bertschy Meier, D; Bilancio, A; Pearce, W; Hirsch, E; (2007) Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood , 110 (8) pp. 2940-2947. 10.1182/blood-2007-04-086751.

Ji, H; Rintelen, F; Waltzinger, C; BertschyMeier, D; Pearce, W; Hirsch, E; Wymman, M; (2007) Inactivation of PI3Kg and PI3Kd distorts T cell development and renders susceptibility to multiple organ inflammation. INFLAMMATION RESEARCH , 56 S444-S444.

Jim, JH; Dhami, P; King, A; Cooper, J; Vetrie, D; (2007) Identification of target genes of an erythroid transcription factor complex containing SCL (TAL1). In: BLOOD. (pp. 85B - 86B). AMER SOC HEMATOLOGY

Joerger, M; Huitema, ADR; Richel, DJ; Dittrich, C; Pavlidis, N; Briasoulis, E; Vermorken, JB; (2007) Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , 63 (4) 505 - 505.

Joerger, M; Huitema, ADR; Richel, DJ; Dittrich, C; Pavlidis, N; Briasoulis, E; Vermorken, JB; (2007) Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: A study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group. CLIN CANCER RES , 13 (21) 6410 - 6418. 10.1158/1078-0432.CCR-07-0064.

Jones, AM; Thirlwell, C; Howarth, KM; Graham, T; Chambers, W; Segditsas, S; Page, KM; (2007) Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas. J PATHOL , 213 (3) 249 - 256. 10.1002/path.2234.

Judith, D; (2007) CT scan plan to combat cancer. Sunday Herald

K

Kandola, S; Anyamene, N; Payne, H; Harland, S; (2007) Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer: a bad experience. BJU INTERNATIONAL , 99 (1) pp. 53-55. 10.1111/j.1464-410X.2007.06543.x.

Kiakos, K; Sato, A; Asao, T; McHugh, PJ; Lee, M; Hartley, JA; (2007) DNA sequence-selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145. MOL CANCER THER , 6 (10) 2708 - 2718. 10.1158/1535-7163.MCT-07-0294.

Kiakos, K.; (2007) Molecular and cellular pharmacology of novel chiral and achiral CC-1065/duocarmycin analogues. Doctoral thesis, University of London. Green open access
file

Kishimoto, H; Ohteki, T; Yajima, N; Kawahara, K; Natsui, M; Kawarasaki, S; Hamada, K; (2007) The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood , 109 (8) pp. 3316-3324. 10.1182/blood-2006-07-038059.

Koch, CM; Andrews, RM; Flicek, P; Dillon, SC; Karaoz, U; Clelland, GK; Wilcox, S; (2007) The landscape of histone modifications across 1% of the human genome in five human cell lines. GENOME RES , 17 (6) 691 - 707. 10.1101/gr.5704207.

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; Hillyer, T; (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy (vol 17, pg 36, 2007). GLYCOBIOLOGY , 17 (10) 1030 - 1030. 10.1093/glycob/cw1053.

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; Hillyer, T; (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. GLYCOBIOLOGY , 17 (1) 36 - 45. 10.1093/glycob/cwl053.

Kogelberg, H; Tolner, B; Thomas, G; Di Cara, D; Ramesh, B; Sodha, S; Lowdell, M; (2007) Generation of a single-chain Fv with binding specificity for the integrin, alpha v beta 6, by rational structure based antibody engineering – a promising agent for cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; Dische, S; (2007) Endogenous markers of two separate hypoxia response pathways (HIF2 alpha and CA9) predict radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) pp. 727-735. 10.1200/jco.2005.02.7474.

Kulkarni, AA; Loddo, M; Leo, E; Rashid, M; Eward, KL; Fanshawe, TR; Butcher, J; (2007) DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. CLIN CANCER RES , 13 (20) 6153 - 6161. 10.1158/1078-0432.CCR-07-0671.

L

Ladenstein, R; Whelan, J; Oberlin, O; Weston, C; Jurgens, H; (2007) Multivariate analysis based risk grouping of Ewing tumours (ET) with extra-pulmonary metastatic disease (EPMD): Final results from the Euro Ewing 99 study. In:

Lai, P; Bomanji, JB; Mahmood, S; Nagabhushan, N; Syed, R; Gacinovic, S; Lee, SM; (2007) Detection of tumour thrombus by (18)F-FDG-PET/CT imaging. EUROPEAN JOURNAL OF CANCER PREVENTION , 16 (1) pp. 90-94. 10.1097/01.cej.0000220641.46470.77.

Latz, J; Adachi, S; Symanowski, J; Nakagawa, K; Tamura, T; Hanna, N; Cullen, M; (2007) Correlation of pemetrexed (PEM) NSCLC exposure-response relationships (ERRS) to clinical study results from western and Japanese patient populations. J THORAC ONCOL , 2 (8) S455 - S456.

Ledermann, JA; Gabra, H; Jayson, GC; Spanswick, VJ; Rustin, GJ; Jitlal, M; James, LE; (2007) Combination chemotherapy with carboplatin and gemcitabine in patients in platinum-resistant ovarian cancer chemotherapy: a phase II study demonstrating inhibition of DNA cross-link repair by gemcitabine. In: EJC SUPPLEMENTS. (pp. 320 - 320). PERGAMON-ELSEVIER SCIENCE LTD

Lee, S-M; Woll, PJ; James, LE; Hatton, M; Ali, K; Spiro, SG; Ali, SR; (2007) A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). In: (pp. S306-S307). LIPPINCOTT WILLIAMS & WILKINS

Lee, S-M; Woll, PJ; Rudd, RM; Gower, NH; Ottensmeier, CH; Ali, K; Spiro, SG; (2007) A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC). In: (pp. S359-S359). LIPPINCOTT WILLIAMS & WILKINS

Lee, SM; Woll, PJ; James, LJ; Hatton, M; Ali, K; Spiro, SG; Ali, SR; (2007) A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). In: (Proceedings) Presidential Symposium. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S306-S307). Journal of Thoracic Oncology

Lee, SM; Woll, PJ; Rudd, ; RM, ; Gower, NH; Ottensmeier, CH; Ali, K; (2007) A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC). In: (Proceedings) Proffered Paper. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S359-). Journal of Thoracic Oncology

Leedham, S; Thirlwell, C; Novelli, M; Tomlinson, I; Wright, N; (2007) Using somatic APC mutations as clonal markers to demonstrate polyclonality in colonic polyps. In: GASTROENTEROLOGY. (pp. A428 - A428). W B SAUNDERS CO-ELSEVIER INC

Leedham, SJ; Thirlwell, C; Hoare, J; Tomlinson, I; Wright, NA; (2007) Using somatic APC mutations as clonal markers in colonic polyps. In: GUT. (pp. A50 - A50). B M J PUBLISHING GROUP

Lewis, IJ; Nooij, MA; Whelan, J; Sydes, MR; Grimer, R; Hogendoorn, PCW; Memon, MA; (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. Journal of the National Cancer Institute , 99 (2) pp. 112-128.

Lewis, IJ; Nooij, MA; Whelan, J; Sydes, MR; Grimer, R; Hogendoorn, PCW; Memon, MA; (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J NATL CANCER I , 99 (2) 112 - 128. 10.1093/inci/djk015.

Lowe, H; Tolner, B; Kogelberg, H; Begent, R; Robson, L; Taylorson, C; Chester, K; (2007) A novel human enzyme with a bis-chloro-phenol prodrug for Antibody Directed Enzyme Prodrug Therapy (ADEPT). In: (Proceedings) NCRI Cancer Conference Proceedings.

Lucy, M; (2007) Why I didn’t have any qualms about taking thalidomide. The Express 56-.

M

Maloney, A; Clarke, PA; Naaby-Hansen, S; Stein, R; Koopman, J-O; Akpan, A; Yang, A; (2007) Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. CANCER RESEARCH , 67 (7) pp. 3239-3253. 10.1158/0008-5472.CAN-06-2968.

Mandeville, HC; Ng, Q; Milner, J; Taylor, NJ; Stirling, JJ; Padhani, AR; d'Arcy, AJ; (2007) CA4P and external beam radiotherapy in prostate cancer with assessment of effect by DCE-MRI. In: (pp. S38-S38).

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Tibballs, J; (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol , 30 (1) pp. 6-25. 10.1007/s00270-006-0062-3.

Marina, N; S Bielack, MS; M Bernstein, TB-B; S Smeland, AH; Whelan, J; (2007) International collaboration is feasible in trials for rare conditions: the EURAMOS experience. In: (pp. Abstract 2-).

Marsh, D; Vigor, K; Kogelberg, H; Tolner, B; Meyer, T; Begent, R; Chana, J; (2007) Antibody targeted magnetic nanoparticles for cancer imaging and therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Martins, C; Gunaratnam, M; Stuart, J; Makwana, V; Greciano, O; Reszka, AP; Kelland, LR; (2007) Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. Bioorg Med Chem Lett , 17 (8) pp. 2293-2298. 10.1016/j.bmcl.2007.01.056.

McCloskey, EV; Beneton, M; Charlesworth, D; Kayan, K; deTakats, D; Dey, A; Orgee, J; (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res , 22 (1) pp. 135-141. 10.1359/jbmr.061008.

Milroy, L-G; Zinzalla, G; Prencipe, G; Michel, P; Ley, SV; Gunaratnam, M; Beltran, M; (2007) Chemical variation of natural-product-like scaffolds: design, synthesis, and biological activity of fused bicyclic acetal derivatives. Angew Chem Int Ed Engl , 46 (14) pp. 2493-2496. 10.1002/anie.200604688.

N

Nashed, BF; Zhang, T; Al-Alwan, M; Srinivasan, G; Halayko, AJ; Okkenhaug, K; Vanhaesebroeck, B; (2007) Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol , 37 (2) pp. 416-424. 10.1002/eji.200636401.

Nehls, O; Okech, T; Hsieh, C-J; Enzinger, T; Sarbia, M; Borchard, F; Gruenagel, H-H; (2007) Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer , 96 (9) pp. 1409-1418. 10.1038/sj.bjc.6603728.

Ng, F; Mastoroudes, H; Paul, E; Davies, N; Tibballs, J; Hochhauser, D; Mayer, A; (2007) A comparison of hickman line- and port-a-cath-associated complications in patients with solid tumours undergoing chemotherapy. CLIN ONCOL-UK , 19 (7) 551 - 556. 10.1016/j.clon.2007.04.003.

Ng, Q-S; Goh, V; Milner, J; Stratford, MR; Folkes, LK; Tozer, GM; Saunders, MI; (2007) Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. The Lancet Oncology , 8 (2) pp. 111-118. 10.1016/S1470-2045(07)70001-3.

Ng, QS; Goh, V; Carnell, D; Meer, K; Padhani, AR; Saunders, MI; Hoskin, PJ; (2007) Tumor antivascular effects of radiotherapy combined with combretastatin A4 phosphate in human non-small-cell lung cancer. International Journal of Radiation Oncology Biology Physics , 67 (5) pp. 1375-1380.

Ng, QS; Goh, V; Milner, J; Padhani, AR; Saunders, MI; Hoskin, PJ; (2007) Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. International Journal of Radiation Oncology Biology Physics , 67 (2) pp. 417-424.

O

O'Hare, CC; Uthe, P; Mackay, H; Blackmon, K; Jones, J; Brown, T; Nguyen, B; (2007) Sequence recognition in the minor groove of DNA by covalently linked formamido imidazole-pyrrole-imidazole polyamides: Effect of H-pin linkage and linker length on selectivity and affinity. BIOCHEMISTRY-US , 46 (42) 11661 - 11670. 10.1021/bi701053a.

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110 delta isoform of Pl3K. TRENDS IN IMMUNOLOGY , 28 (2) 80 - 87. 10.1016/j.it.12.007.

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. Trends in Immunology , 28 (2) 80 - 87. 10.1016/j.it.2006.12.007. Green open access
file

P

Papakonstanti, EA; Ridley, AJ; Vanhaesebroeck, B; (2007) The p110 delta isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO JOURNAL , 26 (13) pp. 3050-3061. 10.1038/sj.emboj.7601763.

Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; Burns, A; (2007) Scleroderma renal crisis-patient characteristics and outcomes in 110 cases from a single centre. In: RHEUMATOLOGY. (pp. I4 - I5). OXFORD UNIV PRESS

Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; Burns, A; (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM-INT J MED , 100 (8) 485 - 494. 10.1093/qjmed/hcm052.

Pepper, C; Lowe, H; Fegan, C; Thurieau, C; Thurston, DE; Hartley, JA; Delavault, P; (2007) Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells. BRIT J CANCER , 97 (2) 253 - 259. 10.1038/sj.bjc.6603853.

Pipinikas, CP; Nair, SB; Kirby, RS; Carter, ND; Fenske, CD; (2007) Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers , 12 (5) pp. 541-557. 10.1080/13547500701391353.

Plummer, ER; Calvert, H; (2007) Targeting poly(ADP-ribose) polymerase: A two-armed strategy for cancer therapy. CLIN CANCER RES , 13 (21) 6252 - 6256. 10.1158/1078-0432.CCR-07-0617.

Plummer, R; Attard, G; Pacey, S; Li, L; Razak, A; Perrett, R; Barrett, M; (2007) Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers. CLIN CANCER RES , 13 (20) 6187 - 6194. 10.1158/1078-0432.CCR-07-0950.

Plummer, R; Vida, L; Perrett, R; Spicer, J; Stopfer, P; Shahidi, M; Temple, G; (2007) A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor. In: EJC SUPPLEMENTS. (pp. 108 - 108). PERGAMON-ELSEVIER SCIENCE LTD

Porschen, R; Arkenau, H-T; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; Kretzschmar, A; (2007) Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. J Clin Oncol , 25 (27) pp. 4217-4223. 10.1200/JCO.2006.09.2684.

Porschen, R; Arkenau, HT; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; Kretzschmar, A; (2007) In reply [10]. Journal of Clinical Oncology , 25 (31) pp. 5045-5046. 10.1200/JCO.2007.13.4841.

Porschen, R; Arkenau, HT; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; Kretzschmar, A; (2007) In reply [8]. Journal of Clinical Oncology , 25 (31) pp. 5042-5043. 10.1200/JCO.2007.14.4386.

R

Rachid, Z; Brahimi, F; Qiu, Q; Williams, C; Hartley, JM; Hartley, JA; Jean-Claude, BJ; (2007) Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: Discovery of an unusual structure-activity relationship. J MED CHEM , 50 (11) 2605 - 2608. 10.1021/jm070144p.

Rades, D; Veninga, T; Stalpers, LJA; Basic, H; Hoskin, PJ; Karstens, JH; Schild, SE; (2007) Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys , 67 (5) pp. 1506-1509. 10.1016/j.ijrobp.2006.11.029.

Roylance, R; Seddon, B; McTiernan, A; Sykes, K; Daniels, S; Whelan, J; (2007) Experience of the use of trabectedin (ET-743, Yondelis (TM)) in 21 patients with pre-treated advanced sarcoma from a single centre. CLIN ONCOL-UK , 19 (8) 572 - 576. 10.1016/j.cton.2007.05.006.

Roylance, R; Seddon, BM; Sykes, K; Beresford, A; Daniels, S; Whelan, J; (2007) Experience of the use of trabectedin (ET-743, Yondelis) in twenty one patients with pre-treated advanced sarcoma from a single centre. Clinical Oncology , 19 (8) pp. 572-576. 10.1016/j.clon.2007.05.006.

Rustin, GJ; Mead, GM; Stenning, SP; Vasey, PA; Aass, N; Huddart, RA; Sokal, MP; (2007) Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - The National Cancer Research Institute Testis Cancer Clinical Studies Group. JOURNAL OF CLINICAL ONCOLOGY , 25 (11) 1310 - 1315. 10.1200/JCO.2006.08.4889.

S

Sainz-Pastor, N; Tolner, B; Robson, L; Parizek, P; Binz, K; Forrer, P; Begent, R; (2007) Selection and evaluation of designed ankyrin repeat proteins (DARPins) reactive with carcinoembryonic antigen (CEA). In: (Proceedings) NCRI Cancer Conference Proceedings.

Sexton, J; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; Kluza, J; Hochhauser, D; (2007) MEDI 309-Regulation of the topoisomerase II alpha gene using polyamides that binds to the inverted CCAAT box present in the promoter. ABSTR PAP AM CHEM S , 234 ? - ?.

Short, SC; Buffa, FM; Bourne, S; Koritzinsky, M; Wouters, BG; Bentzen, SM; (2007) Dose- and time-dependent changes in gene expression in human glioma cells after low radiation doses. RADIATION RESEARCH , 168 (2) pp. 199-208. 10.1667/RR0940.1.

Short, SC; Martindale, C; Bourne, S; Brand, J; Johnston, P; (2007) DNA damage response in gliomas and normal human astrocytes. Neuro-Oncology , 9 (4) pp. 404-411.

Short, SC; Martindale, C; Bourne, SM; Brand, G; Woodcock, M; Johnston, P; (2007) Damage signalling after TMZ and radiation in glioma cells and sensitisation by inhibition of repair in G2. In:

Sielaff, A; Cooper, A; Mackay, H; Brown, T; O'Hare, C; Kluza, J; Kotecha, M; (2007) Binding of f-PIP and JH-37 to the inverted CCAAT box-2 of the topoisomerase II promoter. ABSTR PAP AM CHEM S , 233 613 - 613.

Sikic, BI; Wakelee, HA; Von Mehren, M; Lewis, NL; Plummer, ER; Calvert, AH; Fox, NL; (2007) A phase 1b study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI. MOL CANCER THER , 6 (12) 3454S - 3455S.

Singh, KL; Muttukrishna, S; Stein, RC; McGarrigle, HH; Patel, A; Parikh, B; Groome, NP; (2007) Predictors of ovarian reserve in young women with breast cancer. BRIT J CANCER , 96 (12) 1808 - 1816. 10.1038/sj.bjc.6603814. Gold open access

Sky, NRSM; (2007) Thalidomide could get cancer treatment licence. UNSPECIFIED

Smith, AE; Pinkney, M; Piggott, NH; Calvert, H; Milton, ID; Lunec, J; (2007) Novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues. HYBRIDOMA , 26 (5) 281 - 288. 10.1089/hyb.2007.0512.

Spicer, J; Calvert, H; Vidal, L; Azribi, F; Perrett, R; Shahidi, M; Temple, G; (2007) Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR. J THORAC ONCOL , 2 (8) S410 - S410.

Strauss, SJ; Higginbottom, K; Jüliger, S; Maharaj, L; Allen, P; Schenkein, D; Lister, TA; (2007) The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. Cancer Res , 67 (6) pp. 2783-2790. 10.1158/0008-5472.CAN-06-3254.

Sullivan, A; Lu, X; (2007) ASPP: a new family of oncogenes and tumour suppressor genes. BRITISH JOURNAL OF CANCER , 96 (2) pp. 196-200. 10.1038/sj.bjc.6603525.

Swanton, C; Marani, M; Pardo, O; Warne, PH; Kelly, G; Sahai, E; Elustondo, F; (2007) Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. CANCER CELL , 11 (6) pp. 498-512. 10.1016/j.ccr.2007.04.011.

Swanton, C; Nicke, B; Marani, M; Kelly, G; Downward, J; (2007) Initiation of high frequency multi-drug resistance following kinase targeting by siRNAs. Cell Cycle , 6 (16) pp. 2001-2004. 10.4161/cc.6.16.4538.

T

Thirlwell, C; Howarth, KM; Segditsas, S; Guerra, G; Thomas, HJW; Phillips, RKS; Talbot, IC; (2007) Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations. BRIT J CANCER , 96 (11) 1729 - 1734. 10.1038/sj.bjc.6603789.

Tolner, B; Smith, L; Hillyer, T; Bhatia, J; Beckett, P; Robson, L; Sharma, SK; (2007) From laboratory to Phase I/II cancer trials with recombinant biotherapeutics. EUR J CANCER , 43 (17) 2515 - 2522. 10.1016/j.ejca.2007.08.027.

Toumpanakis, C; Meyer, T; Caplin, ME; (2007) Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM , 21 (1) pp. 131-144. 10.1016/j.beem.2007.01.005.

Toumpanakis, C; Quigley, A; Srirajaskanthan, R; Karpathakis, A; Krepska, A; Davidson, A; Meyer, T; (2007) The new radiolabelled somatostatin analogue 90Yttrium-dota-octreotate for the treatment of metastatic neuroendocrine tumors: Initial results and tolerability in a series of 47 patients. In: (Proceedings) Annual Meeting of the British-Society-of-Gastroenterology. (pp. A42-A43). B M J PUBLISHING GROUP

U

Ullah, MZ; Bhargava, A; Jamal-Hanjani, M; Jacob, S; (2007) Totally extra-peritoneal repair of inguinal hernia by a glove-balloon: technical innovation. Surgeon , 5 (4) pp. 245-247.

V

Vassileva, V; Grant, J; De Souza, R; Allen, C; Piquette-Miller, M; (2007) Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 60 (6) pp. 907-914. 10.1007/s00280-007-0449-0.

Von, MG; Vogel, P; Schmidt, M; Eidtmann, H; Cufer, T; De Jongh, F; Maartense, E; (2007) Trastuzumab treatment beyond progression in patients with HER-2 positive metastatic breast cancer - the TBP study (GBG 26/BIG 3-05). In: (pp. S185-S185).

W

Westbury, CB; Pearson, A; Nerurkar, A; Reis-Filho, JS; Steele, D; Peckitt, C; Sharp, G; (2007) Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. BRIT J RADIOL , 80 (959) 934 - 938. 10.1259/bjr/25046649.

Whelan, J; Dolbear, C; Mak, V; Moller, H; Davies, E; (2007) Where do teenagers and young adults receive treatment for cancer? J PUBLIC HEALTH-UK , 29 (2) 178 - 182. 10.1093/pubmed/fdm006.

Whelan, J; Smeland, S; Marina, N; Bernstein, M; Sydes, MR; Butterfass-Bahoul, T; Perisoglou, M; (2007) Successful pan-European and trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECTEUROCORES). In:

Whelan, J; Smeland, S; Marina, N; Bernstein, M; Sydes, MR; May, B; Butterfass-Bahloui, T; (2007) Successful pan-European and trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES). In: EJC SUPPLEMENTS. (pp. 408 - 409). PERGAMON-ELSEVIER SCIENCE LTD

Whelan, J; Smeland S, MN; Bernstein M, SM; May E, B-BT; Perisoglou M, CD; Calaminus G, MR; Hogendoorn P, UB; (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In:

Whelan, J; Sydes, M; Bielack, S; Smeland, S; Marina, N; May, E; Butterfass-Bahloul, T; (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In:

Whelan, JLI; Nooij M, SM; Grimer R, HP; Memon M, WS; Uscinska B, VGM; Kirkpatrick A, HE; Craft A, TOBOTMRCBO06AEORTC80931CAEOI; (2007) Intensified chemotherapy improved histological response but not survival in patients with operable osteosarcoma of an extremity: results of a randomised phase III study of the European Osteosarcoma Intergroup (MRC BO06 80931 ISRCTN86294690). Journal of the National Cancer Institute , 99 pp. 112-128.

Wilkins, D; Mayer, A; Sharma, S; Tolner, B; Springer, C; Hartley, J; Boxer, G; (2007) Interim Results of a Phase I/II Trial of Antibody Directed Enzyme Prodrug Therapy (ADEPT) in Patients with Gastrointestinal Carcinoma. In: (Proceedings) NCRI Cancer Conference Proceedings.

Wood, K; Saunders, MI; Honess, DJ; Maxwell, RJ; Wilson, J; Paul, RL; Marsden, PK; (2007) Evaluation of the effects of blood flow on 64Cu-ATSM distribution in a rodent tumour model. In: (Proceedings) International Meeting on Innovative Approaches in Head and Neck Oncology. (pp. S35-S36). ELSEVIER IRELAND LTD

Wood, KA; Hoskin, PJ; Saunders, MI; (2007) Positron emission tomography in oncology: A review. CLIN ONCOL-UK , 19 (4) 237 - 255. 10.1016/j.clon.2007.02.001.

Wylie, JP; Mandall, P; Bottomley, D; Hoskin, PJ; (2007) Multi-institutional UK prostate brachytherapy database. In: (pp. S50-S51).

Wynne, P; Newton, C; Ledermann, J; Olaitan, A; Mould, TA; Hartley, JA; (2007) Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy. BRIT J CANCER , 97 (7) 927 - 933. 10.1038/sj.bjc.6603973.

This list was generated on Sun Apr 23 02:54:52 2017 BST.